Home
Shopping Cart
Contact Us
IRBD.ORG
EUBF.ORG
All Enquiries:: +44 (0)20 8487 1421  
  Search:      Advanced search
 
Printable version 
 
     Categories
Journal - Volume 3
Journal - Volume 2
Journal - Volume 1
FREE Articles
Short Communications
Subscriptions


     Help
Contact us
Privacy statement
Terms & Conditions
Editorial Board
Company Info

  ASPOFAFF :: Journal - Volume 1 :: Issue 1 :: Vol 1 - Iss 1 - Article - Oxcarbazepine — Alternative treatment in Bipolar Disorders

  Vol 1 - Iss 1 - Article - Oxcarbazepine — Alternative treatment in Bipolar Disorders #7
Vol 1 - Iss 1 - Article - Oxcarbazepine — Alternative treatment in Bipolar Disorders  Oxcarbazepine — Alternative treatment in Bipolar Disorders

Authors :Detlef E. Dietrich, MD and Hinderk M. Emrich, MD, PhD
Affiliation: Department of Clinical Psychiatry and Psychotherapy, Medical School Hanover, Germany

Correspondence and requests for reprints should be addressed to:
Detlef E. Dietrich, MD
Department of Clinical Psychiatry and Psychotherapy
OE 7110, Medical School Hannover
30623 Hannover, Germany
Tel.: +49 511 532 6749
Fax: +49 511 532 2415
E-mail: dietrich.detlef@mh-hannover.de

Abstract

Objectives:
The anticonvulsants carbamazepine and valproate have successfully been used in pharmacopsychiatry after their therapeutic value in affective and schizoaffective disorders was documented in several clinical trials. Oxcarbazepine (OXC), a keto-derivative of carbamazepine, which had already shown antimanic efficacy in clinical studies since the early 80s, is now being further investigated regarding antimanic and potential mood stabilizing effects.
Methods:
Reports of antimanic and mood stabilizing effects of oxcarbazepine during the last 20 years are reviewed up to April 2003. Efficacy and side effects were compared with other mood stabilizers and discussed regarding possible future indications of this compound.
Results:
According to the literature OXC is regarded as effective in acute mania and appears to reduce the dosage of neuroleptics required for the treatment of affective and schizoaffective disorders. In addition, it has a preferable pharmacokinetic profile with less severe side effects compared to other anticonvulsants and neuroleptics, and co-administration with neuroleptics or antidepressants appears to be well tolerated in affective disorders.
Conclusions:
Despite the promising effects of OXC, few clinical studies have been published in the last 20 years. We conclude that further studies should validate the antimanic efficacy of OXC and evaluate possible pharmacopsychiatric indications, as well as limitations for this psychotropic compound.

Key Words: Oxcarbazepine - OXC – affective disorders – mania – mood-stabilizer – depression

Download the Article for FREE

Details
 
Price: €0.01

Options
 
Quantity

 Add to cart 
        

 

  Send to friend
Your name: *
Your e-mail: *
Recipient's e-mail: *

 Send to friend 
 

 

 
     Your cart
Cart is empty

View cart
Checkout


     Authentication
Username

Password

Log in
Register
Recover password

If Javascript is disabled in your browser click here




 

  Powered by X-Cart: shopping cart software Copyright © 2005-2008 ASPOFAFF